ERICA CARTER: Open Payments
NPI 1023889086 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,508 in 114 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $694 · 2025 $2,508
Food & beverage: $2,313Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $661 |
| ABBVIE INC. | 39 | $588 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $260 |
| GENZYME CORPORATION | 8 | $218 |
| Amgen Inc. | 8 | $161 |
| UCB, Inc. | 9 | $159 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Organon LLC | 6 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Lilly USA, LLC | 1 | $64 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, Winlevi, OTEZLA, Bimzelx, VTAMA.
Industry payments across VA — which companies pay providers there.
